PROGYNY INC (PGNY)
US74340E1038 - Common Stock
Taking everything into account, PGNY scores 7 out of 10 in our fundamental rating. PGNY was compared to 116 industry peers in the Health Care Providers & Services industry. PGNY gets an excellent profitability rating and is at the same time showing great financial health properties. PGNY is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, PGNY could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
PGNY had positive earnings in the past year.
PGNY had a positive operating cash flow in the past year.
Of the past 5 years PGNY 4 years were profitable.
Of the past 5 years PGNY 4 years had a positive operating cash flow.
1.2 Ratios
PGNY's Return On Assets of 7.71% is amongst the best of the industry. PGNY outperforms 92.17% of its industry peers.
Looking at the Return On Equity, with a value of 10.72%, PGNY is in the better half of the industry, outperforming 79.13% of the companies in the same industry.
The Return On Invested Capital of PGNY (9.80%) is better than 88.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 8.77%.
The last Return On Invested Capital (9.80%) for PGNY is above the 3 year average (8.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.71% | ||
| ROE | 10.72% | ||
| ROIC | 9.8% |
ROA(3y)10.72%
ROA(5y)8.95%
ROE(3y)15.14%
ROE(5y)13.15%
ROIC(3y)8.61%
ROIC(5y)7.94%
1.3 Margins
PGNY's Profit Margin of 5.53% is amongst the best of the industry. PGNY outperforms 82.61% of its industry peers.
PGNY's Profit Margin has declined in the last couple of years.
PGNY's Operating Margin of 5.93% is fine compared to the rest of the industry. PGNY outperforms 68.70% of its industry peers.
In the last couple of years the Operating Margin of PGNY has grown nicely.
Looking at the Gross Margin, with a value of 21.88%, PGNY is in line with its industry, outperforming 43.48% of the companies in the same industry.
In the last couple of years the Gross Margin of PGNY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 5.53% | ||
| GM | 21.88% |
OM growth 3Y28.9%
OM growth 5YN/A
PM growth 3Y-24.95%
PM growth 5YN/A
GM growth 3Y2.58%
GM growth 5Y3.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
Compared to 1 year ago, PGNY has more shares outstanding
The number of shares outstanding for PGNY has been increased compared to 5 years ago.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 9.40 indicates that PGNY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.40, PGNY belongs to the best of the industry, outperforming 96.52% of the companies in the same industry.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.4 |
ROIC/WACC1.07
WACC9.19%
2.3 Liquidity
A Current Ratio of 3.31 indicates that PGNY has no problem at all paying its short term obligations.
PGNY has a Current ratio of 3.31. This is amongst the best in the industry. PGNY outperforms 88.70% of its industry peers.
A Quick Ratio of 3.31 indicates that PGNY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.31, PGNY belongs to the best of the industry, outperforming 88.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.31 | ||
| Quick Ratio | 3.31 |
3. Growth
3.1 Past
PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.86%, which is quite impressive.
The Earnings Per Share has been growing by 97.89% on average over the past years. This is a very strong growth
PGNY shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.94%.
The Revenue has been growing by 59.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.86%
EPS 3Y97.89%
EPS 5YN/A
EPS Q2Q%-5.56%
Revenue 1Y (TTM)26.94%
Revenue growth 3Y46.69%
Revenue growth 5Y59.52%
Sales Q2Q%7.62%
3.2 Future
The Earnings Per Share is expected to grow by 31.83% on average over the next years. This is a very strong growth
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.46% yearly.
EPS Next Y18.12%
EPS Next 2Y31.78%
EPS Next 3Y22.23%
EPS Next 5Y31.83%
Revenue Next Year13.47%
Revenue Next 2Y14.76%
Revenue Next 3Y15.33%
Revenue Next 5Y18.46%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 44.18, the valuation of PGNY can be described as expensive.
PGNY's Price/Earnings ratio is in line with the industry average.
PGNY is valuated expensively when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.03 indicates a quite expensive valuation of PGNY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PGNY is on the same level as its industry peers.
PGNY's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.07.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.18 | ||
| Fwd PE | 25.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PGNY is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 88.70% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.48 | ||
| EV/EBITDA | 27.94 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PGNY's earnings are expected to grow with 22.23% in the coming years.
PEG (NY)2.44
PEG (5Y)N/A
EPS Next 2Y31.78%
EPS Next 3Y22.23%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PROGYNY INC
NASDAQ:PGNY (5/31/2024, 7:00:00 PM)
After market: 26.95 0 (0%)26.95
+0.33 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.57B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.18 | ||
| Fwd PE | 25.03 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.71% | ||
| ROE | 10.72% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 5.93% | ||
| PM (TTM) | 5.53% | ||
| GM | 21.88% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.31 | ||
| Quick Ratio | 3.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)41.86%
EPS 3Y97.89%
EPS 5Y
EPS Q2Q%
EPS Next Y18.12%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.94%
Revenue growth 3Y46.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y